PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Mar-2026 eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer Businesswire
12-Mar-2026 AM Best Affirms Credit Ratings of Torreyana Insurance Company, Inc. Businesswire
12-Mar-2026 Onco-Innovations Announces Closing of Private Placement ACCESS Newswire
12-Mar-2026 NADMED Partners with Altheome to Bring Advanced NAD Testing to UK Clinics and Consumers NADMED
12-Mar-2026 Five PGIM Funds Recognized by 2026 LSEG Lipper Fund Awards Businesswire
12-Mar-2026 Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing Businesswire
12-Mar-2026 FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer Businesswire
12-Mar-2026 RQM+ Launches SMART Solutions Life Cycle Partnership Model Businesswire
12-Mar-2026 eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium ACCESS Newswire
12-Mar-2026 Otsuka Unveils New Repinatrabit Open-Label Extension Data in Phenylketonuria (PKU) Signaling Efficacy in Adolescents at the 2026 American College of Medical Genetics and Genomics (ACMG) Meeting Businesswire
12-Mar-2026 Champions Oncology Reports Revenue of $16.6 Million ACCESS Newswire
12-Mar-2026 Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences Businesswire
12-Mar-2026 Waiv Secures $33 Million to Scale AI Precision Testing Businesswire
12-Mar-2026 PsiQuantum and National Cancer Center Japan Announce New Strategic Partnership to Accelerate Drug Discovery for Healthcare Businesswire
12-Mar-2026 Xiid Becomes Security Backbone for EV, Healthcare AI, and Specialized Cloud and DevOps Consultancy Businesswire
12-Mar-2026 Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study Intensity Therapeutics, Inc.
12-Mar-2026 Dosell AB signs framework agreement with Adda following the end of the appeal period Dosell AB
12-Mar-2026 Shilpa Biologicals and mAbTree Biologics Secure Orphan Drug Designation from U.S. FDA Shilpa Biologicals
12-Mar-2026 Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management Abbott
12-Mar-2026 Asylon Robotics Announces New Advisors, Additions to Leadership Team Businesswire